Obesity boosts ovarian cancer risk, study finds
Obesity is probably a factor in some of the almost 22,000 new diagnoses of ovarian cancer that will be handed out this year to American women, a new study says. The finding adds ovarian cancer, the deadliest of the gynecological malignancies, to a growing list of diseases linked to carrying far too much weight.
Research has found obesity to contribute to a person’s risk for a wide range of illnesses, including cardiovascular disease, type 2 diabetes, and cancers of the breast, colon, pancreas and esophagus.
In the case of ovarian cancer, which affects 8 in 100,000 women in the United States, the role of obesity is small: about 5% of U.S. cases of this deadly cancer might be attributable, at least in part, to a woman’s obesity, concluded the American Institute for Cancer Research and the World Cancer Research Fund, which released a report on ovarian cancer Tuesday.
If American women maintained a healthy weight - with body mass index lower than 30 - the report calculates that 1,112 cases of ovarian cancer might be prevented each year.
The report also concludes that a woman’s tall stature puts her at higher risk of ovarian cancer. But it notes that tallness itself does not appear to confer that greater risk; rather, some of the factors that result in tallness may also contribute to tumor establishment and growth, the experts suggested. Taller people have been found to be at greater risk for a wide range of other cancers as well.
Ovarian cancer typically progresses with no recognizable symptoms, and as a result is often diagnosed in advanced stages, when it is harder to treat. Ovarian cancer claims the lives of about 14,000 women in the United States annually, a number that has scarcely budged in 40 years.
It is far more common in post-menopausal women - almost 70% of those diagnosed with ovarian cancer are older than 54. But the new study found that obese pre-menopausal women have a more elevated risk of ovarian cancer (compared with non-obese pre-menopausal women) than do obese post-menopausal women (compared with their non-obese peers).
The cancer specialists who drafted the report cited mounting evidence that obesity-induced disturbances both of the metabolism and of sex hormones probably explain the link between obesity and ovarian cancer. High levels of the hunger hormone leptin, and of circulating insulin - both more common in the obese - spur an increase in growth factors that promote tumors. And accumulated fat can be a powerful producer of estrogen, which can fuel some cancer growth.
Get our free Coronavirus Today newsletter
Sign up for the latest news, best stories and what they mean for you, plus answers to your questions.
You may occasionally receive promotional content from the Los Angeles Times.